These variants might have an essential role in pathogenesis of TOF and DORV, suggesting that ZFPM2/FOG2 genetic variations might be potential biomarkers and therapeutic targets for non-syndromic TOF and DORV. This evidence concerns the gene ZFPM2 and double outlet right ventricle.